Caradonna S, Muller-Weeks S
Department of Molecular Biology, University of Medicine and Dentistry of New Jersey, School of Osteopathic Medicine, Two Medical Center Drive, Stratford, NJ 08084, USA.
Curr Protein Pept Sci. 2001 Dec;2(4):335-47. doi: 10.2174/1389203013381044.
The absence of uracil from DNA genomes is a consequence of enzyme functions that eliminate intracellular dUTP pools and that purposefully recognize and remove uracil moieties from DNA. These enzymatic functions are dUTP nucleotidohydrolase (dUTPase) and uracil-DNA glycosylase (UDG), respectively. There are distinct nuclear and mitochondrial isoforms of each of these enzymes in human cells. The mitochondrial isoform of dUTPase (DUT-M) begins as a 31 kilodalton precursor protein containing an arginine-rich, amino-terminal presequence required for targeting to the mitochondria. This precursor is processed into a 23 kilodalton protein that resides, in mature form, in the mitochondria. The nuclear isoform of dUTPase (DUT-N) is an 18 kilodalton protein. Both species of dUTPase are nearly identical except for their amino-termini. Analysis of protein expression reveals that DUT-M is constitutive and independent of cell cycle phase or proliferation status of the cell. In contrast, DUT-N protein and mRNA levels are tightly regulated to coincide with nuclear DNA replication. The common sequence for both nuclear and mitochondrial isoforms includes a cyclin-dependent kinase consensus site. However, only the nuclear form appears to be phosphorylated at this site in vivo. Studies on dUTPase genomic organization reveal that both isoforms are encoded by the same gene. Isoform specific transcripts arise through the use of alternate 5' exons. Uracil-DNA glycosylase (UDG1) is but one of a growing family of enzymes that repairs potentially mutagenic events caused by uracil in DNA. Human cells contain two isoforms of UDG1 which are also nearly identical except for their amino termini. One isoform (UDG1-M), which is constitutively expressed, is targeted to the mitochondria. This form originates as a 35,000 dalton precursor and is N-terminally processed to a mature 29,000 dalton protein as it transits into the mitochondria. The other isoform is targeted to the nucleus and its expression is a function of cellular proliferation status. As with dUTPase, UDG1 isoform specific transcripts arise through the use of alternate 5prie; exons. Both of these enzymatic functions are a unique illustration, in humans, of the use of alternate exons to generate differentially expressed proteins targeted to different organelles. There are questions as to whether the nuclear isoform of UDG (UDG1-N) is also processed (at the N-terminus) to a lower molecular weight form. Polyclonal antisera generated to the unique N-terminal region of this isoform, reveals that UDG1-N exists as a 36,000 dalton protein in human cell nuclei. Since the epitope for this antibody resides in the first 24 amino acids of UDG1-N, it is apparent that the majority of this isoform is not processed and retains its amino terminus. Evidence also indicates that UDG1-N exists as a serine/threonine phosphoprotein and that phosphorylation occurs in the unique N-terminal region. This was initially deduced from the observation that nuclear UDG1-N migrates as multiple bands on SDS-PAGE and as a single band subsequent to phosphatase treatment. Cdc2 kinase is at least one of the enzymes that can phosphorylate UDG1-N. This review will summarize the current information on isoform characteristics of both dUTPase and uracil-DNA glycosylase. It will also focus on evidence for phosphorylation and speculate as to the purpose of these post-translational events.
DNA基因组中不存在尿嘧啶是酶功能作用的结果,这些酶能消除细胞内的dUTP池,并能有目的地识别和去除DNA中的尿嘧啶部分。这些酶功能分别是dUTP核苷酸水解酶(dUTPase)和尿嘧啶-DNA糖基化酶(UDG)。人类细胞中每种酶都有不同的核型和线粒体型异构体。dUTPase的线粒体异构体(DUT-M)最初是一种31千道尔顿的前体蛋白,其富含精氨酸的氨基末端前序列是靶向线粒体所必需的。该前体被加工成一种23千道尔顿的蛋白,以成熟形式存在于线粒体中。dUTPase的核异构体(DUT-N)是一种18千道尔顿的蛋白。除了氨基末端外,这两种dUTPase几乎完全相同。蛋白质表达分析表明,DUT-M是组成型的,与细胞周期阶段或细胞增殖状态无关。相比之下,DUT-N蛋白和mRNA水平受到严格调控,与核DNA复制同步。核型和线粒体型异构体的共同序列包括一个细胞周期蛋白依赖性激酶共有位点。然而,只有核型在体内似乎在此位点被磷酸化。对dUTPase基因组组织的研究表明,这两种异构体由同一基因编码。异构体特异性转录本通过使用不同的5'外显子产生。尿嘧啶-DNA糖基化酶(UDG1)只是修复DNA中由尿嘧啶引起的潜在诱变事件的酶家族中不断增加的一员。人类细胞含有两种UDG1异构体,除了氨基末端外也几乎完全相同。一种组成型表达的异构体(UDG1-M)靶向线粒体。这种形式最初是一种35000道尔顿的前体,在进入线粒体时其氨基末端被加工成成熟的29000道尔顿蛋白。另一种异构体靶向细胞核,其表达是细胞增殖状态的函数。与dUTPase一样,UDG1异构体特异性转录本通过使用不同的5'外显子产生。这两种酶功能是人类利用不同外显子产生靶向不同细胞器的差异表达蛋白的独特例证。关于UDG的核异构体(UDG1-N)是否也(在氨基末端)被加工成较低分子量形式存在疑问。针对该异构体独特氨基末端区域产生的多克隆抗血清表明,UDG1-N在人类细胞核中以36000道尔顿蛋白的形式存在。由于该抗体的表位位于UDG1-N的前24个氨基酸中,显然该异构体的大部分未被加工并保留其氨基末端。证据还表明,UDG1-N以丝氨酸/苏氨酸磷酸蛋白的形式存在,磷酸化发生在独特的氨基末端区域。这最初是从以下观察结果推断出来的:核UDG1-N在SDS-PAGE上迁移为多条带,而在磷酸酶处理后迁移为单一条带。Cdc2激酶至少是能够磷酸化UDG1-N的酶之一。本综述将总结关于dUTPase和尿嘧啶-DNA糖基化酶异构体特征的当前信息。它还将关注磷酸化的证据,并推测这些翻译后事件的目的。